Reports from Catholic University of Louvain (UCLouvain) Advance Knowledge in Lung Cancer (Case report: BRAF A598-T599insV mutation as a potential resistance mechanism to alectinib in ALK-rearranged lung adenocarcinoma)

    Press/Media: Expert Comment

    Period23 Nov 2022

    Media coverage

    1

    Media coverage